Estée Lauder stock holds after hold rating and earnings on August 19
Published on 08/17/2026 at 12:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Estée Lauder Companies Inc. (US5184391044) is trading near $86, with a $31.13 billion market value and a 52-week range of $66.22 to $121.64 as of August 17, 2026. The stock is also facing a fresh analyst read-through, with one widely tracked broker summary showing a Hold consensus and an average 12-month target of $96.95.
Analyst tone stays cautious
A broker roundup published on August 17, 2026 said 21 analysts now split into 10 Hold ratings, eight Buys, two Sells and one Strong Buy, which leaves the average view at Hold. That same snapshot put the stock at $86.05 at the open and framed the latest target range between $80 and $95, a narrow band that suggests little conviction in a sharp re-rating.
The comparison matters: the average target of $96.95 sits only 12.7 percent above the $86.05 opening price, while the 52-week low of $66.22 and high of $121.64 show how far the shares have already moved in the past year. For investors, the gap between the current quote and the target band is smaller than the stock's full-year swing.
Results arrive on August 19
Finlogix's earnings calendar lists Estée Lauder for August 19, 2026, with consensus looking for $0.32 in EPS and $3.55 billion in revenue. Zacks also said on August 17, 2026 that the quarter ended June 2026 is expected to show earnings of $0.32 a share and revenue of $3.55 billion, with EPS estimates revised 0.13 percent lower over the last 30 days.
That setup leaves a clear test: the market is entering the report with expectations for a year-over-year EPS increase of 255.6 percent and revenue growth of 4.1 percent, while the latest reported quarter in the same Zacks note showed $0.91 in EPS versus an expected $0.66, a 37.88 percent surprise. The next print will show whether that beat pattern can extend.
Complexion science angle
GuruFocus said on August 16, 2026 that the company entered a collaborative research agreement with the University of Leeds' School of Design and Dr. Kaida Xiao to advance color science and consumer skin perception insights. The product and research angle is straightforward for a prestige beauty group: shade matching, formulation quality and consumer perception can matter as much as headline advertising.
Historically, the same GuruFocus page said EL's price-to-sales ratio stood at 2.11 versus a historical median of 3.9x, and it cited a negative trailing-twelve-month EPS of -0.7. That makes the current debate less about a simple valuation multiple and more about whether margins and profitability can keep recovering into the next report.
Stock and product view
Among Estée Lauder's better-known brands, Clinique remains a representative business line because it sits at the intersection of skincare, makeup and fragrance. The portfolio mix matters for the August 19 report because premium skincare and makeup trends tend to drive both revenue mix and margin tone.
Estée Lauder stock last traded at $86.10 on August 14, 2026, with a market cap of $31.15 billion, a 52-week high of $121.64 and a 52-week low of $64.83. That puts the shares below both the 50-day moving average of $84.20 and the 200-day average of $87.23 in the same market snapshot.
Fact box
Company: The Estée Lauder Companies Inc.
ISIN: US5184391044
Ticker: EL
Exchange: NYSE
Price (as of August 14, 2026, 4:00 p.m. ET): $86.10 USD
Market cap: $31.15 billion (as of August 14, 2026)
Sector / Industry: Consumer Staples / Personal Products
Index membership: S&P 500
